Rochelle Stenzler

Ottawa biotech firm says it is restructuring in the wake of a “higher-than-expected level of inconclusive results” from its rapid COVID-19 testing device.
Chief executive Roger Eacock says rapid COVID-19 tests are poised to make local biotech company a force on the 'international stage.'